Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C43H68ClNO11 |
Molecular Weight | 810.453 |
Optical Activity | ( - ) |
Defined Stereocenters | 14 / 14 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12O[C@](O)([C@H](C)C[C@@H]1OC)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O[C@@]([H])([C@H](C)[C@@H](O)CC(=O)[C@H](CC)\C=C(C)\C[C@H](C)C[C@@H]2OC)C(\C)=C\[C@@H]4CC[C@H](Cl)[C@@H](C4)OC
InChI
InChIKey=KASDHRXLYQOAKZ-XDSKOBMDSA-N
InChI=1S/C43H68ClNO11/c1-10-30-18-24(2)17-25(3)19-36(53-8)39-37(54-9)21-27(5)43(51,56-39)40(48)41(49)45-16-12-11-13-32(45)42(50)55-38(28(6)33(46)23-34(30)47)26(4)20-29-14-15-31(44)35(22-29)52-7/h18,20,25,27-33,35-39,46,51H,10-17,19,21-23H2,1-9H3/b24-18+,26-20+/t25-,27+,28+,29-,30+,31-,32-,33-,35+,36-,37-,38+,39+,43+/m0/s1
Molecular Formula | C43H68ClNO11 |
Molecular Weight | 810.453 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 14 / 14 |
E/Z Centers | 1 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:55:37 UTC 2023
by
admin
on
Fri Dec 15 15:55:37 UTC 2023
|
Record UNII |
7KYV510875
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C146638
Created by
admin on Fri Dec 15 15:55:37 UTC 2023 , Edited by admin on Fri Dec 15 15:55:37 UTC 2023
|
||
|
NDF-RT |
N0000175458
Created by
admin on Fri Dec 15 15:55:37 UTC 2023 , Edited by admin on Fri Dec 15 15:55:37 UTC 2023
|
||
|
WHO-VATC |
QD11AH02
Created by
admin on Fri Dec 15 15:55:37 UTC 2023 , Edited by admin on Fri Dec 15 15:55:37 UTC 2023
|
||
|
NDF-RT |
N0000175457
Created by
admin on Fri Dec 15 15:55:37 UTC 2023 , Edited by admin on Fri Dec 15 15:55:37 UTC 2023
|
||
|
WHO-ATC |
D11AH02
Created by
admin on Fri Dec 15 15:55:37 UTC 2023 , Edited by admin on Fri Dec 15 15:55:37 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
7632
Created by
admin on Fri Dec 15 15:55:37 UTC 2023 , Edited by admin on Fri Dec 15 15:55:37 UTC 2023
|
PRIMARY | |||
|
Pimecrolimus
Created by
admin on Fri Dec 15 15:55:37 UTC 2023 , Edited by admin on Fri Dec 15 15:55:37 UTC 2023
|
PRIMARY | |||
|
7KYV510875
Created by
admin on Fri Dec 15 15:55:37 UTC 2023 , Edited by admin on Fri Dec 15 15:55:37 UTC 2023
|
PRIMARY | |||
|
321952
Created by
admin on Fri Dec 15 15:55:37 UTC 2023 , Edited by admin on Fri Dec 15 15:55:37 UTC 2023
|
PRIMARY | RxNorm | ||
|
DTXSID2046674
Created by
admin on Fri Dec 15 15:55:37 UTC 2023 , Edited by admin on Fri Dec 15 15:55:37 UTC 2023
|
PRIMARY | |||
|
SUB16457MIG
Created by
admin on Fri Dec 15 15:55:37 UTC 2023 , Edited by admin on Fri Dec 15 15:55:37 UTC 2023
|
PRIMARY | |||
|
100000091732
Created by
admin on Fri Dec 15 15:55:37 UTC 2023 , Edited by admin on Fri Dec 15 15:55:37 UTC 2023
|
PRIMARY | |||
|
2168
Created by
admin on Fri Dec 15 15:55:37 UTC 2023 , Edited by admin on Fri Dec 15 15:55:37 UTC 2023
|
PRIMARY | |||
|
137071-32-0
Created by
admin on Fri Dec 15 15:55:37 UTC 2023 , Edited by admin on Fri Dec 15 15:55:37 UTC 2023
|
PRIMARY | |||
|
CHEMBL1200686
Created by
admin on Fri Dec 15 15:55:37 UTC 2023 , Edited by admin on Fri Dec 15 15:55:37 UTC 2023
|
PRIMARY | |||
|
6509979
Created by
admin on Fri Dec 15 15:55:37 UTC 2023 , Edited by admin on Fri Dec 15 15:55:37 UTC 2023
|
PRIMARY | |||
|
7KYV510875
Created by
admin on Fri Dec 15 15:55:37 UTC 2023 , Edited by admin on Fri Dec 15 15:55:37 UTC 2023
|
PRIMARY | |||
|
PIMECROLIMUS
Created by
admin on Fri Dec 15 15:55:37 UTC 2023 , Edited by admin on Fri Dec 15 15:55:37 UTC 2023
|
PRIMARY | |||
|
MM-12
Created by
admin on Fri Dec 15 15:55:37 UTC 2023 , Edited by admin on Fri Dec 15 15:55:37 UTC 2023
|
PRIMARY | |||
|
m8811
Created by
admin on Fri Dec 15 15:55:37 UTC 2023 , Edited by admin on Fri Dec 15 15:55:37 UTC 2023
|
PRIMARY | Merck Index | ||
|
C47671
Created by
admin on Fri Dec 15 15:55:37 UTC 2023 , Edited by admin on Fri Dec 15 15:55:37 UTC 2023
|
PRIMARY | |||
|
DB00337
Created by
admin on Fri Dec 15 15:55:37 UTC 2023 , Edited by admin on Fri Dec 15 15:55:37 UTC 2023
|
PRIMARY | |||
|
C117268
Created by
admin on Fri Dec 15 15:55:37 UTC 2023 , Edited by admin on Fri Dec 15 15:55:37 UTC 2023
|
PRIMARY | |||
|
6783
Created by
admin on Fri Dec 15 15:55:37 UTC 2023 , Edited by admin on Fri Dec 15 15:55:37 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SOLVATE->ANHYDROUS | |||
|
BINDER->LIGAND |
BINDING
|
||
|
TARGET -> INHIBITOR |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
EXCRETED UNCHANGED |
Based on the results of the aforementioned radiolabeled study, following a single oral dose of pimecrolimus ~81% of the administered radioactivity was recovered, primarily in the feces (78.4%) as metabolites. Less than 1% of the radioactivity found in the feces was due to unchanged pimecrolimus.
FECAL
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||
Tmax | PHARMACOKINETIC |
|
|
|||